المؤلفون: Dilawari, A., Rentscher, K. E., Zhai, W., Zhou, X., Ahles, T. A., Ahn, J., Bethea, T. N., Carroll, J. E., Cohen, H. J., Graham, D. A., Jim, H. S. L., McDonald, B., Nakamura, Z. M., Patel, S. K., Root, J. C., Small, B. J., Saykin, A. J., Tometich, D., Van Dyk, K., Mandelblatt, J. S.

المساهمون: National Cancer Institute, National Institutes of Health, National Institute on Aging, Norman Cousins Center for Psychoneuroimmunology, American Cancer Society

المصدر: Breast Cancer Research and Treatment ; volume 190, issue 2, page 287-293 ; ISSN 0167-6806 1573-7217

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1007/s10549-021-06362-wTest

المؤلفون: Lange, M., Joly, F., Vardy, J, Ahles, T., Dubois, M., Tron, L., Winocur, G., De Ruiter, M.B., Castel, H.

المساهمون: The Cancer and Cognition Platform, French Ligue contre le Cancer

المصدر: Annals of Oncology ; volume 30, issue 12, page 1925-1940 ; ISSN 0923-7534

الإتاحة: https://doi.org/10.1093/annonc/mdz410Test
https://api.elsevier.com/content/article/PII:S092375342032562X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342032562X?httpAccept=text/plainTest

المؤلفون: Phillips, K.A., Regan, M.M., Ribi, K., Francis, P.A., Puglisi, F., Bellet, M., Spazzapan, S., Karlsson, P., Budman, D.R., Zaman, K., Abdi, E.A., Domchek, S.M., Feng, Y., Price, K.N., Coates, A.S., Gelber, R.D., Maruff, P., Boyle, F., Forbes, J.F., Ahles, T., Fleming, G.F., Bernhard, J.

المصدر: British journal of cancer, vol. 114, no. 9, pp. 956-964

مصطلحات موضوعية: Adjuvants, Immunologic, Adult, Antineoplastic Agents, Hormonal/therapeutic use, Breast Neoplasms/complications, Breast Neoplasms/drug therapy, Cognition, Female, Humans, Middle Aged, Ovary/metabolism, Premenopause, Quality of Life, Tamoxifen/therapeutic use

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27092785; info:eu-repo/semantics/altIdentifier/eissn/1532-1827; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_6782EAEE877A2; https://serval.unil.ch/notice/serval:BIB_6782EAEE877ATest; urn:issn:0007-0920; https://serval.unil.ch/resource/serval:BIB_6782EAEE877A.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_6782EAEE877A2Test

الإتاحة: https://doi.org/10.1038/bjc.2016.71Test
https://serval.unil.ch/notice/serval:BIB_6782EAEE877ATest
https://serval.unil.ch/resource/serval:BIB_6782EAEE877A.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_6782EAEE877A2Test

المؤلفون: Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., Schagen, S. B.

مصطلحات موضوعية: reviews

وصف الملف: text/html

العلاقة: http://annonc.oxfordjournals.org/cgi/content/short/19/4/623Test; http://dx.doi.org/10.1093/annonc/mdm500Test

الإتاحة: https://doi.org/10.1093/annonc/mdm500Test
http://annonc.oxfordjournals.org/cgi/content/short/19/4/623Test

المؤلفون: Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., Schagen, S. B.

مصطلحات موضوعية: review

وصف الملف: text/html

العلاقة: http://annonc.oxfordjournals.org/cgi/content/short/mdm500v1Test; http://dx.doi.org/10.1093/annonc/mdm500Test

الإتاحة: https://doi.org/10.1093/annonc/mdm500Test
http://annonc.oxfordjournals.org/cgi/content/short/mdm500v1Test

المؤلفون: Wasson, JH, Ahles, T, Bazos, D, Bracken, A, Patterson, JA, Johnson, DJ

المصدر: European Journal of Clinical Nutrition ; volume 53, issue S2, page s97-s100 ; ISSN 0954-3007 1476-5640

مصطلحات موضوعية: Nutrition and Dietetics, Medicine (miscellaneous)

الإتاحة: https://doi.org/10.1038/sj.ejcn.1600811Test
https://www.nature.com/articles/1600811.pdfTest
https://www.nature.com/articles/1600811Test

المؤلفون: Coombs, D., Saunders, R. L., Maurer, L. H., Vernier, K., Ahles, T.

المصدر: Anesthesiology ; volume 75, issue 3, page A741-A741 ; ISSN 0003-3022

الإتاحة: https://doi.org/10.1097/00000542-199109001-00740Test
https://pubs.asahq.org/anesthesiology/article-pdf/75/3/A741/640914/0000542-199109001-00740.pdfTest

المؤلفون: Smith, E.M.L., Pang, H., Ye, C., Cirrincione, C., Fleishman, S., Paskett, E.D., Ahles, T., Bressler, L.R., Le‐lindqwister, N., Fadul, C.E., Loprinzi, C., Shapiro, C.L.

مصطلحات موضوعية: chemotherapyâ induced peripheral neuropathy, pain, oxaliplatin, Duloxetine, Hematology and Oncology, Health Sciences

وصف الملف: application/pdf

العلاقة: Smith, E.M.L.; Pang, H.; Ye, C.; Cirrincione, C.; Fleishman, S.; Paskett, E.D.; Ahles, T.; Bressler, L.R.; Le‐lindqwister, N.; Fadul, C.E.; Loprinzi, C.; Shapiro, C.L. (2017). "Predictors of duloxetine response in patients with oxaliplatinâ induced painful chemotherapyâ induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial â CALGB/alliance 170601." European Journal of Cancer Care 26(2): n/a-n/a.; https://hdl.handle.net/2027.42/136306Test; European Journal of Cancer Care; Mols F., Beijers T., Vreugdenhil G. & van de Pollâ Franse L. ( 2014 ) Chemotherapyâ induced peripheral neuropathy and its association with quality of life: a systematic review. Supportive Care in Cancer 22, 2261 â 2269.; Meltzerâ Brody S., Leserman J., Zolnoun D., Steege J., Green E. & Teich A. ( 2007 ) Trauma and posttraumatic stress disorder in women with chronic pelvic pain. Obstetrics and Gynecology 109, 902 â 908.; Miaskowski C., Paul S.M., Cooper B., West C., Levine J.D., Elboim C., Hamolsky D., Abrams G., Luce J., Dhruva A., Langford D.J., Merriman J.D., Kober K., Baggott C., Leutwyler H. & Aouizerat B.E. ( 2014 ) Identification of patient subgroups and risk factors for persistent arm/shoulder pain following breast cancer surgery. European Journal of Oncology Nursing 18, 242 â 253.; Nail L. ( 2011 ) Symptoms and physical function following treatment among people with chemotherapyâ induced peripheral neuropathy. Oncology Nursing Forum 38, A48 â A49.; Park S.B., Lin C.S., Krishnan A.V., Goldstein D., Friedlander M.L. & Kiernan M.C. ( 2009 ) Oxaliplatinâ induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain 132, 2712 â 2723.; Park S.B., Lin C.S., Krishnan A.V., Friedlander M.L., Lewis C.R. & Kiernan M.C. ( 2011 ) Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxelâ induced neuropathy. Muscle and Nerve 43, 367 â 374.; Persohn E., Canta A., Schoepfer S., Traebert M., Mueller L., Gilardini A., Galbiati S., Nicolini G., Scuteri A., Lanzani F., Giussani G. & Cavaletti G. ( 2005 ) Morphological and morphometric analysis of paclitaxel and docetaxelâ induced peripheral neuropathy in rats. European Journal of Cancer 41, 1460 â 1466.; Peters C.M., Jimenezâ Andrade J.M., Jonas B.M., Sevcik M.A., Koewler N.J., Ghilardi J.R., Wong G.Y. & Mantyh P.W. ( 2007 ) Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Experimental Neurology 203, 42 â 54.; Plotti F., Sansone M., Di Donato V., Antonelli E., Altavilla T., Angioli R. & Panici P.B. ( 2011 ) Quality of life and sexual function after type C2/type III radical hysterectomy for locally advanced cervical cancer: a prospective study. The Journal of Sexual Medicine 8, 894 â 904.; Postma T.J., Aaronson N.K., Heimans J.J., Muller M.J., Hildebrand J.G., Delattre J.Y., Hoangâ Xuan K., Lanteriâ Minet M., Grant R., Huddart R., Moynihan C., Maher J. & Lucey R. and EORTC Quality of Life Group ( 2005 ) The development of an EORTC quality of life questionnaire to assess chemotherapyâ induced peripheral neuropathy: the QLQâ CIPN20. European Journal of Cancer 41, 1135 â 1139.; Raphael K.G. & Widom C.S. ( 2011 ) Postâ traumatic stress disorder moderates the relation between documented childhood victimization and pain 30 years later. Pain 152, 163 â 169.; Renn C.L., Carozzi V.A., Rhee P., Gallop D., Dorsey S.G. & Cavaletti G. ( 2011 ) Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatinâ based chemotherapy in mice. Molecular Pain 7, 29.; Royâ Byrne P.P., Davidson K.W., Kessler R.C., Asmundson G.J., Goodwin R.D., Kubzansky L., Lydiard R.B., Massie M.J., Katon W., Laden S.K. & Stein M.B. ( 2008 ) Anxiety disorders and comorbid medical illness. General Hospital Psychiatry 30, 208 â 225.; Schreiber K.L., Martel M.O., Shnol H., Shaffer J.R., Greco C., Viray N., Taylor L.N., McLaughlin M., Brufsky A., Ahrendt G., Bovbjerg D., Edwards R.R. & Belfer I. ( 2013 ) Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain. Pain 154, 660 â 668.; Smith E.M., Cohen J.A., Pett M.A. & Beck S.L. ( 2010 ) The reliability and validity of a modified total neuropathy scoreâ reduced and neuropathic pain severity items when used to measure chemotherapyâ induced peripheral neuropathy in patients receiving taxanes and platinums. Cancer Nursing 33, 173 â 183.; Smith E.M., Pang H., Cirrincione C., Fleishman S., Paskett E.D., Ahles T., Bressler L.R., Fadul C.E., Knox C., Leâ Lindqwister N., Gilman P.B. & Shapiro C.L. and Alliance for Clinical Trials in Oncology ( 2013 ) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapyâ induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309, 1359 â 1367.; Sonneveld P. & Jongen J.L. ( 2010 ) Dealing with neuropathy in plasmaâ cell dyscrasias. Hematology 2010, 423 â 430.; Sullivan M.J., Thorn B., Haythornthwaite J.A., Keefe F., Martin M., Bradley L.A. & Lefebvre J.C. ( 2001 ) Theoretical perspectives on the relation between catastrophizing and pain. Clinical Journal of Pain 17, 52 â 64.; Taylor R.S. ( 2006 ) Epidemiology of refractory neuropathic pain. Pain Practice 6, 22 â 26.; Taylor A.P., Adelman J.U. & Freeman M.C. ( 2007 ) Efficacy of duloxetine as a migraine preventive medication: possible predictors of response in a retrospective chart review. Headache 47, 1200 â 1203.; Theunissen M., Peters M.L., Bruce J., Gramke H.F. & Marcus M.A. ( 2012 ) Preoperative anxiety and catastrophizing: a systematic review and metaâ analysis of the association with chronic postsurgical pain. The Clinical Journal of Pain 28, 819 â 841; Tofthagen C. ( 2010 ) Patient perceptions associated with chemotherapyâ induced peripheral neuropathy. Clinical Journal of Oncology Nursing 14, E22.; Tofthagen C. ( 2011 ) Relationships between chemotherapyâ induced peripheral neuropathy, depressive symptoms, and sleep quality in colorectal cancer patients previously treated with oxaliplatin. Oncology Nursing Forum 38, A55 â A56.; Tofthagen C., Donovan K.A., Morgan M.A., Shibata D. & Yeh Y. ( 2013 ) Oxaliplatinâ induced peripheral neuropathy’s effects on healthâ related quality of life of colorectal cancer survivors. Supportive Care in Cancer 21, 3307 â 3313.; Warren J.W., Howard F.M., Cross R.K., Good J.L., Weissman M.M., Wesselmann U., Langenberg P., Greenberg P. & Clauw D.J. ( 2009 ) Antecedent nonbladder syndromes in caseâ control study of interstitial cystitis/painful bladder syndrome. Urology 73, 52 â 57.; Wilson R.H., Lehky T., Thomas R.R., Quinn M.G., Floeter M.K. & Grem J.L. ( 2002 ) Acute oxaliplatinâ induced peripheral nerve hyperexcitability. Journal of Clinical Oncology 20, 1767 â 1774.; Windebank A.J. & Grisold W. ( 2008 ) Chemotherapyâ induced neuropathy. Journal of the Peripheral Nervous System 13, 27 â 46.; Yarnitsky D., Granot M., Nahmanâ Averbuch H., Khamaisi M. & Granovsky Y. ( 2012 ) Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 153, 1193 â 1198.; Zelman D.C., Brandenburg N.A. & Gore M. ( 2006 ) Sleep impairment in patients with painful diabetic peripheral neuropathy. Clinical Journal of Pain 22, 681 â 685.; Zhang Y. & Jordan J. ( 2008 ) Epidemiology of osteoarthritis. Rheumatic Diseases Clinics of North America 34, 515.; Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., Filiberti A., Flechtner H., Fleishman S.B. & de Haes J.C. ( 1993 ) The European Organization for Research and Treatment of Cancer QLQâ C30: a qualityâ ofâ life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 85, 365 â 376.; Allen K.D., Renner J.B., Devellis B., Helmick C.G. & Jordan J.M. ( 2008 ) Osteoarthritis and sleep: the Johnston County Osteoarthritis Project. Journal of Rheumatology 35, 1102 â 1107.; Almadrones L., McGuire D.B., Walczak J.R., Florio C.M. & Tian C. ( 2004 ) Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group study. Oncology Nursing Forum Online 31, 615 â 623.; Altman D.G. ( 1991 ) Practical Statistics for Medical Research translated by Anonymous Chapman & Hall, London, UK.; Argyriou A.A., Iconomou G. & Kalofonos H.P. ( 2008a ) Bortezomibâ induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood 112, 1593 â 1599.; Argyriou A.A., Koltzenburg M., Polychronopoulos P., Papapetropoulos S. & Kalofonos H.P. ( 2008b ) Peripheral nerve damage associated with administration of taxanes in patients with cancer. Critical Reviews in Oncologyâ Hematology 66, 218 â 228.; Argyriou A.A., Zolota V., Kyriakopoulou O. & Kalofonos H.P. ( 2010 ) Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents. Journal of BUON 15, 435 â 446.; Argyriou A.A., Bruna J., Marmiroli P. & Cavaletti G. ( 2012 ) Chemotherapyâ induced peripheral neurotoxicity (CIPN): an update. Critical Reviews in Oncologyâ Hematology 82, 51 â 77.; Baccini F., Pallotta N., Calabrese E., Pezzotti P. & Corazziari E. ( 2003 ) Prevalence of sexual and physical abuse and its relationship with symptom manifestations in patients with chronic organic and functional gastrointestinal disorders. Digestive and Liver Disease 35, 256 â 261.; Bair M.J., Robinson R.L., Katon W. & Kroenke K. ( 2003 ) Depression and pain comorbidity: a literature review. Archives of Internal Medicine 163, 2433 â 2445.; Bakitas M.A. ( 2007 ) Background noise: the experience of chemotherapyâ induced peripheral neuropathy. Nursing Research 56, 323 â 331.; Baron R., Binder A. & Wasner G. ( 2010 ) Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurology 9, 807 â 819.; Barry D.T., Beitel M., Cutter C.J., Garnet B., Joshi D., Rosenblum A. & Schottenfeld R.S. ( 2011 ) Exploring relations among traumatic, posttraumatic, and physical pain experiences in methadoneâ maintained patients. Journal of Pain 12, 22 â 28.; Beijers A.J., Mols F. & Vreugdenhil G. ( 2014 ) A systematic review on chronic oxaliplatinâ induced peripheral neuropathy and the relation with oxaliplatin administration. Supportive Care in Cancer 22, 1999 â 2007.; Benoit E., Brienza S. & Dubois J.M. ( 2006 ) Oxaliplatin, an anticancer agent that affects both Na+ and K+ channels in frog peripheral myelinated axons. General Physiology and Biophysics 25, 263 â 276.; Bruce J., Thornton A.J., Powell R., Johnston M., Wells M., Heys S.D., Thompson A.M., Smith W.C., Chambers W.A. & Scott N.W. ( 2014 ) Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a populationâ based cohort study. Pain 155, 232 â 243.; Bruner D.W., Barsevick A., Tian C., Randall M., Mannel R., Cohn D.E., Sorosky J. & Spirtos N.M. ( 2007 ) Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. Quality of Life Research 16, 89 â 100.; Bymaster F.P., Beedle E.E., Findlay J., Gallagher P.T., Krushinski J.H., Mitchell S., Robertson D.W., Thompson D.C., Wallace L. & Wong D.T. ( 2003 ) Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake. Bioorganic and Medicinal Chemistry Letters 13, 4477 â 4480.; Calhoun E.A., Welshman E.E., Chang C.H., Lurain J.R., Fishman D.A., Hunt T.L. & Cella D. ( 2003 ) Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Groupâ Neurotoxicity (Fact/GOGâ Ntx) questionnaire for patients receiving systemic chemotherapy. International Journal of Gynecological Cancer 13, 741 â 748.; Campbell C.M. & Edwards R.R. ( 2009 ) Mindâ body interactions in pain: the neurophysiology of anxious and catastrophic painâ related thoughts. Translational Research 153, 97 â 101.; Campbell J.C. & Lewandowski L.A. ( 1997 ) Mental and physical health effects of intimate partner violence on women and children. Psychiatric Clinics of North America 20, 353 â 374.; Castillo R., MacKenzie E., Wegener S. & Bosse M. ( 2006 ) Prevalence of chronic pain seven years following limb threatening lower extremity trauma. Pain 124, 321.; Cata J.P., Weng H.R., Chen J.H. & Dougherty P.M. ( 2006 ) Altered discharges of spinal wide dynamic range neurons and downâ regulation of glutamate transporter expression in rats with paclitaxelâ induced hyperalgesia. Neuroscience 138, 329 â 338.; Cavaletti G., Tredici G., Petruccioli M.G., Dondè E., Tredici P., Marmiroli P., Minoia C., Ronchi A., Bayssas M. & Griffon Etienne G. ( 2001 ) Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. European Journal of Cancer 37, 2457 â 2463.; Cavenagh J., Good P. & Ravenscroft P. ( 2006 ) Neuropathic pain: are we out of the woods yet? Internal Medicine Journal 36, 251 â 255.; Cella D., Peterman A., Hudgens S., Webster K. & Socinski M.A. ( 2003 ) Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapyâ taxane (FACTâ taxane). Cancer 98, 822 â 831.; Clark M.R., Heinberg L.J., Haythornthwaite J.A., Quatranoâ Piacentini A.L., Pappagallo M. & Raja S.N. ( 2000 ) Psychiatric symptoms and distress differ between patients with postherpetic neuralgia and peripheral vestibular disease. Journal of Psychosomatic Research 48, 51.; Clauw D.J. & Chrousos G.P. ( 1997 ) Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. NeuroImmunoModulation 4, 134.; Cleeland C.S. ( 2009 ) The Brief Pain Inventory User Guide. Available at: http://www.mdanderson.org/education-and-research/departments-programs-and-labs/departments-and-divisions/symptom-research/symptom-assessment-tools/BPI_UserGuide.pdfTest (accessed July 28, 2009).; Cleeland C.S., Gonin R., Hatfield A.K., Edmonson J.H., Blum R.H., Stewart J.A. & Pandya K.J. ( 1994 ) Pain and its treatment in outpatients with metastatic cancer. New England Journal of Medicine, 330, 592 â 596 (33 ref).; Clemens J.Q., Meenan R., O’Keeffe Rosetti M.C., Kimes T. & Calhoun E. ( 2008 ) Caseâ control study of medical comorbidities in women with interstitial cystitis. The Journal of Urology 179, 2222 â 2225.; Coker A.L., Smith P.H., Bethea L., King M.R. & McKeown R.E. ( 2000 ) Physical health consequences of physical and psychological intimate partner violence. Archives of Family Medicine 9, 451 â 457.; Desaulniers G.A. ( 2011 ) Chemotherapy induced peripheral neuropathy and subjective sleep quality in nonâ small cell lung cancer. Oncology Nursing Forum 38, A56.; Dworkin R.H. ( 2002 ) An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clinical Journal of Pain 18, 343 â 349.; Dworkin R.H., Turk D.C., McDermott M.P., Peirceâ Sandner S., Burke L.B., Cowan P., Farrar J.T., Hertz S., Raja S.N., Rappaport B.A., Rauschkolb C. & Sampaio C. ( 2009 ) Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain 146, 238 â 244.; Edwards R.R., Bingham C.O. 3rd, Bathon J. & Haythornthwaite J.A. ( 2006 ) Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis and Rheumatism 55, 325 â 332.; Edwards R.R., Calahan C., Mensing G., Smith M. & Haythornthwaite J.A. ( 2011 ) Pain, catastrophizing, and depression in the rheumatic diseases. Nature Reviews Rheumatology 7, 216 â 224.; Fishbain D.A., Detke M.J., Wernicke J., Chappell A.S. & Kajdasz D.K. ( 2008 ) The relationship between antidepressant and analgesic responses: findings from six placeboâ controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder. Current Medical Research and Opinion 24, 3105 â 3115.; Flatters S.J.L. & Bennett G. ( 2006 ) Studies of peripheral sensory nerves in paclitaxelâ induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122, 245.; Fleiss J.L. ( 1981 ) Statistical Methods for Rates and Proportions, 2nd edn, translated by Anonymous. John Wiley & Sons, New York, NY, USA.; Fukuda K., Dobbins J.G., Wilson L.J., Dunn R.A., Wilcox K. & Smallwood D. ( 1997 ) An epidemiologic study of fatigue with relevance for the chronic fatigue syndrome. Journal of Psychiatric Research 31, 19.; Fukuda K., Nisenbaum R., Stewart G., Thompson W.W., Robin L., Washko R.M., Noah D.L., Barrett D.H., Randall B., Herwaldt B.L., Mawle A.C. & Reeves W.C. ( 1998 ) Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 280, 981.; Geber C., Breimhorst M., Burbach B., Egenolf C., Baier B., Fechir M., Koerber J., Treede R.D., Vogt T. & Birklein F. ( 2013 ) Pain in chemotherapyâ induced neuropathyâ more than neuropathic? Pain 154, 2877 â 2887.; Geisser M.E., Gracely R.H., Giesecke T., Petzke F.W., Williams D.A. & Clauw D.J. ( 2007 ) The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome. European Journal of Pain 11, 202 â 207.; Geisser M.E., Glass J.M., Rajcevska L.D., Clauw D.J., Williams D.A., Kileny P.R. & Gracely R.H. ( 2008a ) A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls. Journal of Pain 9, 417 â 422.; Geisser M.E., Strader Donnell C., Petzke F., Gracely R.H., Clauw D.J. & Williams D.A. ( 2008b ) Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Psychosomatics 49, 235 â 242.; Giesecke T., Williams D., Harris R., Cupps T., Tian X., Tian T., Gracely R. & Clauw D. ( 2003 ) Subgrouping of fibromyalgia patients on the basis of pressureâ pain thresholds and psychological factors. Arthritis and Rheumatism 48, 2916.; Golding J.M. ( 1999 ) Sexual assault history and headache: five general population studies. Journal of Nervous and Mental Disease 187, 624 â 629.; Gore M., Brandenburg N., Dukes E., Hoffman D., Tai K. & Stacey B. ( 2005 ) Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. Journal of Pain and Symptom Management 30, 374.; Gore M., Brandenburg N., Hoffman D., Tai K. & Stacey B. ( 2006 ) Burden of illness in painful diabetic peripheral neuropathy: the patientsâ perspectives. The Journal of Pain 7, 892.; Grolleau F., Gamelin L., Boisdronâ Celle M., Lapied B., Pelhate M. & Gamelin E. ( 2001 ) A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltageâ gated sodium channels. Journal of Neurophysiology 85, 2293 â 2297.; Hausheer F.H., Schilsky R.L., Bain S., Berghorn E.J. & Lieberman F. ( 2006 ) Diagnosis, management, and evaluation of chemotherapyâ induced peripheral neuropathy. Seminars in Oncology 33, 15 â 49.; Heitkemper M. & Jarrett M. ( 2005 ) Overlapping conditions in women with irritable bowel syndrome. Urologic Nursing, 25, 25 â 30 Quiz 31.; Hershman D.L., Lacchetti C., Dworkin R.H., Lavoie Smith E.M., Bleeker J., Cavaletti G., Chauhan C., Gavin P., Lavino A., Lustberg M.B., Paice J., Schneider B., Smith M.L., Smith T., Terstriep S., Wagnerâ Johnston N., Bak K. & Loprinzi C.L. ( 2014 ) Prevention and management of chemotherapyâ induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 32, 1941 â 1967; Hjermstad M.J., Fossa S.D., Bjordal K. & Kaasa S. ( 1995 ) Test/retest study of the European Organization for Research and Treatment of Cancer Core Qualityâ ofâ Life Questionnaire. Journal of Clinical Oncology 13, 1249 â 1254.; Humphreys J., Cooper B.A. & Miaskowski C. ( 2010 ) Differences in depression, posttraumatic stress disorder, and lifetime trauma exposure in formerly abused women with mild versus moderate to severe chronic pain. Journal of Interpersonal Violence 25, 2316 â 2338.; Jin H.W., Flatters S.J., Xiao W.H., Mulhern H.L. & Bennett G.J. ( 2008 ) Prevention of paclitaxelâ evoked painful peripheral neuropathy by acetylâ Lâ carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Experimental Neurology 210, 229 â 237.; Kautio A.L., Haanpaa M., Kautiainen H., Kalso E. & Saarto T. ( 2011 ) Burden of chemotherapyâ induced neuropathy â a crossâ sectional study. Supportive Care in Cancer 19, 1991 â 1996.; Kiser D.W., Greer T.B., Wilmoth M.C., Dmochowski J. & Naumann R.W. ( 2010 ) Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: patient reports and provider assessments. Oncology Nursing Forum 37, 758 â 764.; Krishnan A.V., Goldstein D., Friedlander M. & Kiernan M.C. ( 2005 ) Oxaliplatinâ induced neurotoxicity and the development of neuropathy. Muscle and Nerve 32, 51 â 60.; Marangell L.B., Clauw D.J., Choy E., Wang F., Shoemaker S., Bradley L., Mease P. & Wohlreich M.M. ( 2011 ) Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine. Pain 152, 31 â 37.

الإتاحة: https://doi.org/10.1111/ecc.12421Test
https://hdl.handle.net/2027.42/136306Test

المؤلفون: Loprinzi, C, Smith, E, Pang, HMH, Ye, C, Cirrincione, C, Fleishman, S, Paskett, E, Ahles, T, Bressler, L, Le-Lindqwister, N, Fadul, C, Shapiro, C

العلاقة: European Journal of Cancer Care; European Journal of Cancer Care, 2015, p. n/a-n/a; n/a; 257897; WOS:000396457700009; eid_2-s2.0-84949921225; http://hdl.handle.net/10722/225799Test

الإتاحة: https://doi.org/10.1111/ecc.12421Test
http://hdl.handle.net/10722/225799Test

المؤلفون: Arndt, J., Das, E., Schagen, S., Reid-Arndt, S., Cameron, L., Ahles, T.

المصدر: Psycho-Oncology, 23, 1, pp. 1-8

مصطلحات موضوعية: Language in Society, Persuasive Communication

العلاقة: https://repository.ubn.ru.nl//bitstream/handle/2066/124119/124119.pdfTest; http://hdl.handle.net/2066/124119Test

الإتاحة: https://doi.org/10.1002/pon.3351Test
http://hdl.handle.net/2066/124119Test
https://repository.ubn.ru.nl//bitstream/handle/2066/124119/124119.pdfTest